NTRK1 and acute myeloid leukemia: The molecular mechanisms of AML chemoresistance to Ara-C have been widely investigated and mainly involve the constitutive activation of tyrosine kinase receptors and intracellular signal transduction molecules such as PI3K, ERK, AKT, mTOR [9, 28, 29].